What is Trinity Guardion?
Trinity Guardion is at the forefront of enhancing patient safety within healthcare facilities through advanced disinfection and reprocessing solutions for hospital mattresses. Their flagship product, the FDA-cleared Soteria Bed Barrier, acts as a crucial protective cover, substantially mitigating contamination risks and the spread of HAIs. Designed for demanding environments such as Neonatal Intensive Care Units (NICUs), Trinity Guardion's offerings are engineered to improve patient outcomes, streamline operational efficiencies in mattress reprocessing, and ensure compliance with stringent manufacturer guidelines. The company's commitment to infection prevention solidifies its role as a key player in the medical device and healthcare technology sector, focusing on critical infection control strategies.
How much funding has Trinity Guardion raised?
Trinity Guardion has raised a total of $63M across 4 funding rounds:
Debt
$135K
Share Placement
$62M
Private Equity
$644K
Private Equity
$218K
Debt (2021): $135K with participation from PPP
Share Placement (2024): $62M led by Market Street Ventures, Tamiami Angel Funds, and Queen City Angels
Private Equity (2025): $644K, investors not publicly disclosed
Private Equity (2026): $218K, investors not publicly disclosed
Key Investors in Trinity Guardion
Market Street Ventures
Market Street Ventures, a holding company with a focus on cleaning solutions, likely brings operational expertise and strategic partnerships to Trinity Guardion's growth trajectory in the infection prevention market.
Tamiami Angel Funds
Tamiami Angel Funds, specializing in early-stage investments, provides crucial seed capital and entrepreneurial support, indicating Trinity Guardion's potential for significant early-stage innovation and market disruption.
Queen City Angels
Queen City Angels, an investor network supporting early-stage companies, offers access to funding, mentorship, and experienced guidance, aligning with Trinity Guardion's mission to advance patient safety solutions.
What's next for Trinity Guardion?
With the recent major strategic investment, Trinity Guardion is poised for accelerated growth and product development. The company's focus on combating Healthcare-Acquired Infections (HAIs) through its innovative Soteria Bed Barrier positions it favorably within the expanding market for infection control technologies. Future endeavors will likely involve scaling manufacturing capabilities, expanding market reach to more healthcare institutions, and potentially further research and development into complementary infection prevention solutions. This strategic financing is expected to empower Trinity Guardion to enhance its competitive edge and solidify its impact on patient safety and hospital operational efficiency.
See full Trinity Guardion company page
